Columbia researchers discover that DNA repair falters when cells can’t move damaged DNA to repair centers within the nucleus. The results could lead to better cancer treatments.
Researchers have found that blocking nerve growth factor inhibits the formation of stomach cancers, according to a study in mice.
In a phase 1 study, eight out of 12 patients with relapsed and/or refractory blood cancers responded to a combination of two common chemotherapy drugs.
Three CUMC scientists have been named AAAS Fellows: Max Gottesman, Wei Gu, and Paul Sajda.
Dr. Drake studies the body’s immunological response to radiation therapy and how immunotherapy and radiation therapy can be used in concert to treat cancer.
In mice studies, targeting the SET protein revives p53, a potent tumor suppressor, and prevents cancer growth.